A Biorepository for Coronary Heart Disease in Qatar

CompletedOBSERVATIONAL
Enrollment

2,100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 18, 2018

Study Completion Date

March 18, 2018

Conditions
Coronary Heart Disease (CHD)
Trial Locations (1)

3050

Hamad Medical Corporation, Doha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Hamad Medical Corporation

INDUSTRY